Fisetin Reduces Diabetic Complications
Author Information
Author(s): Pamela Maher, Richard Dargusch, Jennifer L. Ehren, Shinichi Okada, Kumar Sharma, David Schubert
Primary Institution: The Salk Institute for Biological Studies
Hypothesis
Can fisetin prevent the complications of diabetes in vivo by targeting multiple pathways associated with hyperglycemia?
Conclusion
Fisetin lowers the elevation of methylglyoxal-dependent protein glycation associated with diabetes and ameliorates multiple complications of the disease.
Supporting Evidence
- Fisetin reduced kidney hypertrophy and albuminuria in diabetic mice.
- Fisetin increased glyoxalase 1 enzyme activity.
- Fisetin decreased markers of oxidative stress and inflammation in diabetic mice.
- Fisetin improved locomotor activity in the open field test, indicating reduced anxiety.
Takeaway
Fisetin is a natural compound that helps reduce problems caused by diabetes in mice, like kidney damage and anxiety.
Methodology
Akita mice were fed a diet containing fisetin for 18 weeks, and various health parameters were measured.
Potential Biases
Potential bias in the selection of animal models and the interpretation of results.
Limitations
The study was conducted in a mouse model, which may not fully replicate human diabetes.
Participant Demographics
Male Akita mice, a model of type 1 diabetes.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website